CAS 1401728-56-0

NE 52-QQ57

CAS : 1401728-56-0

NE 52-QQ57 is a selective, and orally available antagonist of GPR4(IC50 : 70 nM),with anti-inflammatory activity.

Formule : C₂₄H₂₈N₆O

Degré de pureté : 98.63%

Couleur et forme : Solid

Masse moléculaire : 416.52

Ref: TM-T11461

NE 52-QQ57

CAS : 1401728-56-0

Formule : C₂₄H₂₈N₆O

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 416.5187

Ref: IN-DA01V1QY

2-(4-((2-Ethyl-5,7-Dimethylpyrazolo[1,5-A]Pyrimidin-3-Yl)Methyl)Phenyl)-5-(Piperidin-4-Yl)-1,3,4-Oxadiazole

CAS : 1401728-56-0

2-(4-((2-Ethyl-5,7-Dimethylpyrazolo[1,5-A]Pyrimidin-3-Yl)Methyl)Phenyl)-5-(Piperidin-4-Yl)-1,3,4-Oxadiazole

Degré de pureté : 99%

Masse moléculaire : 416.52g/mol

Ref: 54-OR1023960

NE 52-QQ57

CAS : 1401728-56-0

NE 52-QQ57

Degré de pureté : ≥98%

Masse moléculaire : 416.52g/mol

Ref: 54-BUP05362

NE 52-QQ57

CAS : 1401728-56-0

NE 52-QQ57 is a monoclonal antibody that binds to the tumor necrosis factor receptor (TNFR) and blocks the binding of TNFα to TNFR. It has been shown to inhibit the development of atherosclerotic lesions in mice by preventing the accumulation of macrophages and T cells in the artery wall. NE 52-QQ57 also inhibits tumor growth by inducing apoptosis and cell cycle arrest, which may be due to its ability to inhibit proton production in hypoxic tumor cells. This drug has been shown to be effective against bowel disease, such as inflammatory bowel disease, with t-cell lymphomas being an exception.

Formule : C₂₄H₂₈N₆O

Degré de pureté : Min. 95%

Masse moléculaire : 416.5 g/mol

Ref: 3D-BGC72856